TAK-279

· Takeda

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for TAK-279, covering 2024-05-23 to 2026-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]